Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A study to find a suitable dose of ASP5834 in adults with solid tumors Recruiting

2025-522082-29-00 Locally advanced (unresectable) or metastatic solid tum 1 2026-01-16
Vorasidenib for the treatment of IDH-mutant astrocytoma after standard chemoradiotherapy Recruiting

2024-519404-27-00 IDH-mutant grade 2 or 3 astrocytoma 5 2026-01-16
Phase II randomized trial of XELOX plus DoSTARlimab versus XELOX alone as Consolidation Treatment after Standard Chemoradiation in pMMR/MSS … Recruiting

2024-519798-20-00 pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LAR 4 2026-01-15
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001) Recruiting

2025-522495-84-00 Cancer – Solid Tumors : 1L NSCLC and all other advanced 7 2026-01-14
NEOREM/NEO-1 - NEOREM: Neo-adjuvant Immunotherapy Master Trial for Localized Cancers / NEO-1: Neo-adjuvant immunotherapy in patients with l… Recruiting

2025-522127-95-00 NEOREM: Localized solid malignancies that are eligible 4 2026-01-12
Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy. Recruiting

2023-507106-13-00 Locally advanced rectal cancer 1 2026-01-12
The purpose of this study is to determine whether Tislelizumab, when given as a subcutaneous (SC) injection, reaches the same drug levels in… Recruiting

2025-522862-58-00 Locally advanced unresectable or metastatic gastric or 5 2026-01-09
A trial to learn how safe AZD4360 is, how well it works, and how it moves throughout the body over time in adults with advanced solid tumors Recruiting

2024-518281-27-00 Gastric Cancer, Gastroesophageal Junction Cancer, Bilia 7 2026-01-09
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer Recruiting

2025-521771-31-00 Cervical Cancer 3 2026-01-05
Angiotensin II for more effective radioembolization in liver cancer: the RADIANT study Recruiting

2025-521870-33-00 Liver cancer (primary or secondary) 4 2026-01-05
Early detection of triple negative breast cancer relapse (CUPCAKE) Recruiting

2022-501562-22-01 Triple-negative breast cancer (TNBC) patients at high r 4 2026-01-05
Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) as First-Line Therapy in Adults with Transplant-Ineligible Primary Central Nervou… Recruiting

2025-521144-38-00 Primary Central Nervous System Lymphoma 4 2025-12-23
Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to avoid secondary resections (Re-TURBT) in Non-Muscle Invasive Bladder… Recruiting

2023-507307-64-00 Non-muscle invasive bladder cancer (NMIBC) 6 2025-12-22
Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcom… Recruiting

2024-518167-35-01 Patients with Metastatic Osteosarcoma 4 2025-12-19
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer Recruiting

2025-521003-52-00 HER2 Expressing Advanced Breast Cancer 9 2025-12-19
Efficacy of Tuvusertib in Recurrent IDH mutant Astrocytoma with ATRX mutation, a phase II prospective trial. Recruiting

2025-521843-19-00 IDH1/2-mutated, ATRX-mutated and p53-mutated astrocytom 4 2025-12-19
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants with Advanced Solid Tumors Recruiting

2025-522203-23-00 Advanced Solid Tumors 7 2025-12-18
To compare the Safety and activity of GDC-4198 Alone and in Combination with Giredestrant against Abemaciclib and Giredestrant in Participan… Recruiting

2025-521128-31-00 Locally Advanced or Metastatic Estrogen Receptor-Positi 9 2025-12-18
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carc… Recruiting

2022-500676-59-00 EBV-positive nasopharyngeal carcinoma 4 2025-12-18
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants with Prostate Cancer Recruiting

2024-517653-27-00 Prostate Cancer 4 2025-12-17
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. Recruiting

2024-517002-28-01 graft-versus-host disease 3 2025-12-17
ZANGEA – Phase II Study of Zanidatamab in Combination with Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesopha… Recruiting

2025-522718-22-00 Gastroesophageal Adenocarcinoma 4 2025-12-16
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting

2025-522860-34-00 Chronic lymphocytic leukemia (CLL) 5 2025-12-16
A Study to Test the Safety and Effects of a New Cancer Drug (TUB-030) in Patients with Advanced Solid Tumors Recruiting

2025-522517-35-00 Patients with advanced/metastatic tumors with head and 7 2025-12-16